Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(2-(1h-benzo(d)imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea
2. Daurismo
3. Glasdegib
4. Pf-04449913
1. 2030410-25-2
2. Pf-04449913 Maleate
3. Daurismo
4. Th2ev99s4z
5. 2030410-25-2 (maleate)
6. 1-((2r,4r)-2-(1h-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea Maleate
7. Glasdegib Maleate (jan)
8. Glasdegib Maleate [jan]
9. 1-((2r,4r)-2-(1h-benzimidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)ureamaleatesalt
10. Urea, N-((2r,4r)-2-(1h-benzimidazol-2-yl)-1-methyl-4-piperidinyl)-n'-(4-cyanophenyl)-, (2z)-2-butenedioate (1:1)
11. Pf 04449913 Maleate
12. Daurismo (tn)
13. Unii-th2ev99s4z
14. Chembl4297534
15. Schembl18171548
16. Dtxsid301027747
17. Glasdegib Maleate [who-dd]
18. Glasdegib Maleate [orange Book]
19. D11107
20. Pf-04449913 Maleate Salt, >=98% (hplc)
21. 1-((2r,4r)-2-(1h-benzimidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea Maleate Salt
22. 1-[(2r,4r)-2-(1h-benzimidazol-2-yl)-1-methylpiperidin-4-yl]-3-(4-cyanophenyl)urea;(z)-but-2-enedioic Acid
Molecular Weight | 490.5 g/mol |
---|---|
Molecular Formula | C25H26N6O5 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 490.19646795 g/mol |
Monoisotopic Mass | 490.19646795 g/mol |
Topological Polar Surface Area | 171 Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 714 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (AML) in adult patients who are not candidates for standard induction chemotherapy.
L01XX63
Global Sales Information
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
74
PharmaCompass offers a list of Glasdegib Maleate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glasdegib Maleate manufacturer or Glasdegib Maleate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glasdegib Maleate manufacturer or Glasdegib Maleate supplier.
PharmaCompass also assists you with knowing the Glasdegib Maleate API Price utilized in the formulation of products. Glasdegib Maleate API Price is not always fixed or binding as the Glasdegib Maleate Price is obtained through a variety of data sources. The Glasdegib Maleate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Glasdegib Maleate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glasdegib Maleate, including repackagers and relabelers. The FDA regulates Glasdegib Maleate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glasdegib Maleate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Glasdegib Maleate supplier is an individual or a company that provides Glasdegib Maleate active pharmaceutical ingredient (API) or Glasdegib Maleate finished formulations upon request. The Glasdegib Maleate suppliers may include Glasdegib Maleate API manufacturers, exporters, distributors and traders.
Glasdegib Maleate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glasdegib Maleate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Glasdegib Maleate GMP manufacturer or Glasdegib Maleate GMP API supplier for your needs.
A Glasdegib Maleate CoA (Certificate of Analysis) is a formal document that attests to Glasdegib Maleate's compliance with Glasdegib Maleate specifications and serves as a tool for batch-level quality control.
Glasdegib Maleate CoA mostly includes findings from lab analyses of a specific batch. For each Glasdegib Maleate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glasdegib Maleate may be tested according to a variety of international standards, such as European Pharmacopoeia (Glasdegib Maleate EP), Glasdegib Maleate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glasdegib Maleate USP).